Frequently Asked Questions – ASSIST Study
flirty-close
Loading...

Frequently Asked Questions

Read answers to some of our frequently asked questions about the study.

What is ASSIST?

Alzheimer’s Disease Discovery Study or ASSIST, conducted by Savonix Inc. and Boston University School of Public Health, is a three-year research study to understand better what is normal cognition. It aims to identify the relationships between lifestyle choices such as diet, sleep, exercise, social interactions, as well as other factors and the risk for developing dementia, including Alzheimer’s disease.

How does the ASSIST study work?

The ASSIST study takes about 45 minutes to complete. You are asked to review and sign a consent form, followed by a short questionnaire about your current and prior health conditions.

After you provide consent, the study will direct you to register for the test link. You will download the Savonix Mobile app to take the test on an Android smart device such as a tablet or phone, or an Apple® device such as an iPad® or iPhone®. Savonix Mobile will also ask you to share your Health App data, (for iPhone® user only) including body measurements and your health habits such as exercise, nutrition and sleep. When you have time and are in a quiet space, take the Savonix test. It will measure your cognitive abilities in terms of reaction time, ability to remember numbers, words, and pictures, and to think flexibly.

At the end of the test you can see your result on the Savonix Mobile app. One year after your initial test we will contact you and provide a link to re-test. You will then receive a report of your individual cognitive results as comparing you to other study participants. The study also allows you the options of retesting in the future to see how your cognition changes over time.

To download the step by step guide click here for Android devices such as a tablet or phone, click here for Apple® devices such as an iPad® or iPhone®, and click here for a non-device specific guide.

Why do I need to register?

We need you to create an account so you can access your report.

Why should I participate?

Currently, over 50 million people worldwide have been diagnosed with dementia. It costs an estimated $818 billion a year. Unfortunately, no cure or treatment slows or stops its progression. By taking part in the ASSIST study, you will help scientists better understand how the brain functions at all ages. The study includes how behaviors like sleep and exercise and other health conditions affect our cognitive health. This information can help researchers develop therapies and drugs to target memory loss and move us closer to a cure for Alzheimer’s disease. As part of your participation, you will receive a no-cost study-related neuropsychological screen and personal report when the study ends.

Who can participate?

Anyone who meets all of the following criteria may participate in the study:

22 years or older
A resident of the United States
Has an Apple® device such as an iPad® or iPhone® 5s or later with iOS version 11.0 or later
Uses the Health app to track their health information
Has an Android device such as a tablet or phone: Version 6+

What test will I be taking?

Widely used in Alzheimer's research, the Savonix Mobile test is a clinically validated, neurocognitive test that provides real-time results for: instant and delayed verbal memory, impulse control, attention, focus, emotion identification, information processing speed, flexible thinking, working memory, executive function, visual learning, and spatial memory.

What will I need to do if I participate?

You will complete the online consent forms and health survey to register for the Savonix ASSIST Study. You will download and install the Savonix Mobile app and allow the sharing of your Health app data. At your convenience, you will then complete the Savonix tests. One year later, we will follow-up by email with instructions on how to repeat the Savonix ASSIST tests and share your Health app information.

I think I might have a memory problem. Can I still do the study?

Yes, the study is open to all participants regardless of current health or cognitive conditions. You need to be 22 years or older, a resident of the US, have an Android device such as a tablet or phone: Version 6+; or an Apple® device such as an iPad® or iPhone 5s® or later and uses the Health app to track your health information.

Is this going to cost me anything?

No. Savonix and Boston University School of Public Health are sponsoring this study and have provided the test at no charge.

How long will the study last?

The study will run for around 3 years.

What data will be obtained?

The initial health questionnaire will ask questions about your current and prior health conditions. The Health app on your iPhone® will share your health habits such as exercise, nutrition and sleep over the previous 6 months. You will also be asked to share your electronic health records if you use Health app to store them. Savonix will collect data on your ability to remember, pay attention, problem solve and your reaction time. For the purposes of data analyses, only coded study data (explained below) will be used. Android users will be asked to only complete the health questionnaire and the Savonix digital test.

What happens to my data?

Savonix will store your electronic data in a cloud-based service with password protection and encryption. Your data is kept confidential, except if the law requires the disclosure. You will review the informed consent and authorization documents before the start of the study. When the results of this study are published or presented at meetings, your name, and other directly identifying information will not be used; you will not be identified. Encrypted data communications and transmission with virtual private networking (VPN) technology using AES 256-bit encryption protect external and intra-company communications.

Every effort will be made to protect your data and your confidentiality; however, no system is fail-safe. If such a breach occurs, we will notify you via email.

Your data

Savonix is committed to protecting your privacy and maintaining the security of any personal
information you supply.

We will not share your data for marketing or sales related purposes.

Who will have access to my data?

We will not share your data for marketing or sales related purposes. However, if you agree to participate in the study, you will give us permission to share your identifying information with the following groups of people:

People from Savonix Inc. and Boston University who do the research or help oversee the research.
People from Federal and state agencies who audit or review the research, as required by law.
Academic or private sector research organizations who may wish to contact you for participation in future studies.

If the results of this study are published or presented at meetings, your name and other directly identifying information will not be used; you will not be identified.

Do I have to sign a consent authorization form?

To participate in the study, you are required to sign the consent form. You are under no obligation to participate in the study and may choose not to participate.

Do I get compensated for my time involved in the study?

No.

How long do I have to make up my mind about joining this trial?

You can sign up for this study at your convenience any time before the study ends. We are accepting new participants until December 2020.

Who can I speak with about questions I have during the study?

If you have technical or study-related questions, you may call the Savonix ASSIST helpline at 888-551-8552. If you have any questions about your rights as a research subject, and/or concerns or complaints regarding this research study, contact:

By mail:
Study Subject Adviser
Pro00038177
Columbia Gateway Drive,
Suite 110 Columbia,
MD 21046

or call toll free: 877-992-4724
or by email: [email protected]

What happens if I delete the app?

If you accidentally delete the app, you can redownload it from the App Store® or Google Play by searching for Savonix Mobile. If you did not complete the initial cognitive tests, you will be required to return to the link in the email or text message to start again. The link will expire after 6 weeks. If you had already completed the assessment and deleted the app, you will be asked to redownload the app to participate in the second test.

When can I delete the app?

You can delete the Savonix Mobile app at any time. If you delete the app after the initial cognitive tests and choose to participate in the follow-up test, you will need to download the app again. You may wish to keep the app on your phone for future studies or you may delete it as you wish.

How do I withdraw from the study?

If you decide to withdraw from the study, we ask that you let us know. There is no penalty for discontinuing with the study. You are free to stop at any time. Please contact the principal investigator by mail or email at:

Dr Simon L Collinson DPhil
Savonix Inc
101 California St., Suite 1525
San Francisco, CA 94111
888-551-8552
email: [email protected]

What happens if I upgrade or downgrade my iPhone®?

You can reinstall the Savonix Mobile app at any time. If you backed up your phone, your Savonix Mobile app will be transferred to the new phone.

What happens if I have health issues while participating in the study?

Participation in this study is not a substitute for medical care or medical advice from your doctor or other health care provider. You should continue to see your regular doctor and keep any scheduled physical exams, and medical appointments. Always seek professional medical advice whenever you need it.

What is an Institutional Review Board?

An Institutional Review Board (IRB) is an independent committee established to help protect the rights of research participants. If you have any questions about your rights as a research participant, and/or concerns or complaints regarding this research study, contact:

By mail:
Study Subject Adviser
Pro00038177
Columbia Gateway Drive,
Suite 110 Columbia,
MD 21046

or call toll free: 877-992-4724
or by email: [email protected]